Impact BioMedical Inc.
IBO
$0.43
-$0.01-1.60%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3,893.22% | -806.10% | -438.96% | -469.83% | 118.03% |
| Total Depreciation and Amortization | 14,250.00% | 40.00% | 0.00% | 16.67% | 100.72% |
| Total Amortization of Deferred Charges | -75.13% | 0.90% | 0.18% | -0.18% | -42.81% |
| Total Other Non-Cash Items | 913.30% | 7,700.23% | 6,620.63% | 29,780.28% | -327.35% |
| Change in Net Operating Assets | -200.28% | -174.48% | -167.98% | -239.45% | -10.20% |
| Cash from Operations | -41.03% | -84.32% | -43.34% | -9.58% | 17.26% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -33.33% | 0.00% | 50.00% | -33.33% | 0.00% |
| Cash from Investing | -33.33% | 100.00% | 127.27% | 113.33% | 101.03% |
| Total Debt Issued | -43.50% | -73.24% | -60.92% | -51.34% | -67.24% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -87.68% | 116.00% | 98.93% | 78.71% | 50.22% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -207.66% | 62,300.00% | 131,500.00% | 199,900.00% | 2,367.00% |